Director, Laboratory Sciences and Infectious Disease
Key decision makers in the same organization
Organization Signals
Public Activity & Signals
Board meetings, strategic plans, and buyer signals from Katherine E. Warchut’s organization
Oct 7, 2026·BoardMeeting
Board
Vermont Board of Medical Practice Board Meeting Minutes
The Board discussed public feedback regarding the new IT system for license renewals and staff efforts to improve performance. Administrative updates included the introduction of new staff, approval of the 2027 meeting calendar, and reports on current license renewal statistics. The Board evaluated a pre-application request regarding a criminal conviction and determined it to be disqualifying. Additionally, work groups provided progress updates on the development of foundational principles for artificial intelligence in medicine and licensing pathways for internationally trained physicians. The meeting also featured an executive session to address confidential investigative matters, resulting in the closure of multiple case files.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
Health Equity Advisory Commission Reset Committee Draft Minutes
The committee focused on preparing for an upcoming full Commission meeting and reviewing materials developed through the reset process. The discussion included an analysis of an Integrated Strategic Workplan, which categorizes agency functions, and a review of the draft Charter outlining the Commission's mission, purpose, and scope. The committee reached a consensus to simplify the presentation for the full Commission, prioritizing the agreement on the Charter as the primary focus and identifying other reset documents as works in progress rather than items for immediate approval.
Sep 25, 2026·BoardMeeting
Board
Vermont Immunization Advisory Council Meeting
The Council convened to discuss respiratory virus vaccine recommendations for the upcoming season, including guidance for flu, RSV, and COVID-19 vaccines. Members reviewed the consolidated recommendations aligned with professional medical societies, noting their divergence from federal guidance. Discussions addressed the impact of these changes on vaccine procurement, insurance coverage for mRNA vaccines, and strategies for effectively communicating vaccine guidelines to immunocompromised populations.
The committee reviewed the mission, goals, and legislative funding guardrails regarding the Opioid Abatement Special Fund. Discussions focused on FY28 funding priorities, including outreach workers, syringe service programs, recovery residences, and overdose prevention centers. The committee received an expenditure report on the Opioid Abatement Special Fund, adopted a new program review and sustainability planning form for future funding proposals, and appointed a new Vice Chair. Additionally, public comments were received regarding community-based acupuncture funding, advocacy for individuals with lived experience, and transparency concerns.
Extracted from official board minutes, strategic plans, and video transcripts.
